Curis Inc. (NASDAQ: CRIS)
$3.3400
+0.0900 ( 0% ) 13.3K
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Market Data
Open
$3.3400
Previous close
$3.2500
Volume
13.3K
Market cap
$27.52M
Day range
$3.1400 - $3.3100
52 week range
$3.0500 - $17.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k | Annual reports | 86 | Feb 08, 2024 |
| 8-k | 8K-related | 16 | Feb 08, 2024 |
| 8-k | 8K-related | 30 | Jan 11, 2024 |
| 10-k/a | Quarterly Reports | 15 | Dec 21, 2023 |